Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
暂无分享,去创建一个
[1] I. Laakso,et al. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. , 1997, British journal of clinical pharmacology.
[2] I. Whyte,et al. Overdose with calcium channel blockers , 1994, BMJ.
[3] I. Whyte,et al. Calcium Channel Blockin Drug Overdose: an Australian Series , 1994, Human & experimental toxicology.
[4] T. Litovitz,et al. 1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1993, The American journal of emergency medicine.
[5] A. Dawson,et al. Unusual results of brown snake envenomation , 1993, The Medical journal of Australia.
[6] H. Spiller,et al. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. , 1993, Annals of emergency medicine.
[7] N. Buckley,et al. Slow‐release verapamil poisoning , 1993, The Medical journal of Australia.
[8] L. Dziukas,et al. Drug overdose — reducing the load , 1992, The Medical journal of Australia.
[9] P. Alguire,et al. Case report: fatal overdose with sustained-release verapamil. , 1992, The American journal of the medical sciences.
[10] R. Ferner,et al. Pharmacokinetics and Toxic Effects of Diltiazem in Massive Overdose , 1989, Human toxicology.
[11] L. Kirshenbaum,et al. Whole‐bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified‐release pharmaceuticals , 1989, Clinical pharmacology and therapeutics.
[12] D. McTavish,et al. Verapamil , 2012, Drugs.
[13] P. Neuvonen,et al. Treatment of intoxications using single and repeated doses of oral activated charcoal. , 1989, Journal de toxicologie clinique et experimentale.
[14] H. Jaeger,et al. Quantitative determination of verapamil and metabolites in human serum by high-performance liquid chromatography and its application to biopharmaceutic investigations. , 1989, Arzneimittel-Forschung.
[15] U. Bondesson,et al. Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma. , 1988, Clinical chemistry.
[16] P. Neuvonen,et al. Oral Activated Charcoal in the Treatment of Intoxications , 1988, Medical toxicology and adverse drug experience.
[17] D. T. Lim,et al. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. , 1986, Annals of emergency medicine.
[18] J. Kenny. Calcium channel blocking agents and the heart. , 1985, British medical journal.
[19] M. Scheinin,et al. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin. , 1985, International journal of clinical pharmacology, therapy, and toxicology.
[20] P. Neuvonen,et al. Do gastric contents modify antidotal efficacy of oral activated charcoal? , 1984, British journal of clinical pharmacology.
[21] R. Braithwaite,et al. EFFECT OF ACTIVATED CHARCOAL ON ABSORPTION OF NORTRIPTYLINE , 1977, The Lancet.